3-phenylisoxazoline-5-carboxamide compound and preparation method therefor, herbicidal composition, and use thereof

By developing 3-phenylisoxazoline-5-carboxamide compounds, the problems of selectivity and poor efficacy of existing herbicides have been solved, achieving efficient control of weeds and safety for crops, and making them suitable for a variety of crops and ornamental plants.

WO2026233460A1PCT designated stage Publication Date: 2026-11-12QINGDAO KINGAGROOT CHEM COMPOUNDS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2026/096022
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-08-30
Filing Date
2026-05-09
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing herbicides are not entirely satisfactory in their weed control performance on harmful plants and their selectivity for crops, and there is a market demand for herbicides that are efficient, safe, economical, and have different modes of action.

Method used

A 3-phenylisooxazoline-5-carboxamide compound and its preparation method were developed, which exhibits excellent herbicidal activity against grass weeds, broadleaf weeds, and sedge weeds, and has high selectivity for crops.

Benefits of technology

It achieves efficient control of weeds, especially perennial weeds, without harming economically important crops such as wheat, barley, and corn. It is suitable for genetically modified crops and ornamental plants, and has high selectivity and broad-spectrum activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2026096022_12112026_PF_FP_ABST
    Figure CN2026096022_12112026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of pesticides, and specifically relates to a 3-phenylisoxazoline-5-carboxamide compound and a preparation method therefor, a herbicidal composition, and the use thereof. The compound is represented by general formula I, wherein X represents NR8, O or S; Z represents (II), where the ends a, b, c and d are linked to the group X; Q represents hydrogen, alkyl, OR17 or NR18R19, etc.; R1, R2, R3, R4 and R5 each independently represent hydrogen, halogen, alkyl, etc.; R6, R9, R10, R11, R12, R13, R14, R15 and R16 each independently represent hydrogen, halogen, alkyl, etc.; R17 represents hydrogen, alkyl, etc.; and R7, R8, R18 and R19 each independently represent hydrogen, alkyl, etc. The compound has good herbicidal activity and crop safety
Need to check novelty before this filing date? Find Prior Art

Description

A 3-phenylisoxazoline-5-carboxamide compound, its preparation method, herbicidal composition and application Technical Field

[0001] This invention belongs to the field of pesticide technology, specifically relating to a 3-phenylisooxazoline-5-carboxamide compound, its preparation method, herbicidal composition, and application. Background Technology

[0002] Weed control is a crucial aspect of achieving efficient agriculture, despite the wide variety of herbicides available on the market. However, the weed-control performance and crop selectivity of these known compounds are not entirely satisfactory. Furthermore, due to the expanding market, weed resistance, herbicide lifespan, economic considerations, and increasing environmental awareness, scientists need to continuously research and develop new, efficient, safe, economical herbicides with different modes of action. Summary of the Invention

[0003] This invention provides a 3-phenylisoxazoline-5-carboxamide compound, its preparation method, herbicidal composition, and application. The compound exhibits excellent herbicidal activity against grass weeds, broadleaf weeds, sedges, and other weeds, and is highly selective for crops.

[0004] The technical solution adopted in this invention is as follows:

[0005] A 3-phenylisoxazoline-5-carboxamide compound or a salt thereof, as shown in general formula I:

[0006] Where X represents NR8, O, or S;

[0007] Z represents The a, b, c, and d ends are connected to the group X;

[0008] Q represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, -OR 17 -SR 17 -ON = C(R) 17 )2、-O(CO)NR 18 R 19 -O(CO)OR 17 -(CO)R 17 -(CO)OR 17 -(CO)(CO)OR 17 -(CO)NR 18 R 19 , -NR 18 R 19 or The alkyl, alkenyl, and alkynyl groups are optionally selected from halogens, cyano groups, nitro groups, cycloalkyl groups, aryl groups, heterocyclic groups, and -OR groups. 17 -SR 17 -ON = C(R) 17 )2、-O(CO)NR 18 R 19 -O(CO)OR 17 -(CO)R 17 -(CO)OR 17 -(CO)(CO)OR 17 -(CO)NR 18 R 19 , -NR 18 R 19 or At least one group in it is replaced;

[0009] R1, R2, R3, R4, and R5 independently represent hydrogen, halogen, alkyl, alkenyl, alkynyl, cyano, nitro, cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -N(R)(OR), -N(R)(COR), -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR, or -(CO)N(R)2; wherein the alkyl, alkenyl, or alkynyl group is optionally substituted by at least one group selected from halogen, cyano, nitro, cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, or -(CO)N(R)2;

[0010] R6, R9, R 10 R 11 R 12 R 13 R 14 R 15 R 16 Each of these can independently represent hydrogen, halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, cyano, cyanoalkyl, -OR, -alkylene-OR, -(CO)OR, or cycloalkyl;

[0011] R 17Represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, or heterocyclic; said alkyl, alkenyl, or alkynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)N(R)2, or -(CO)N(R)(OR);

[0012] R7, R8, R 18 R 19 Each of the following groups independently represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, -N(R)2, -N(R)(OR), -COR, -COOR, -OR, -SOR, or -(SO2)R; wherein the alkyl, alkenyl, or alkynyl group is optionally substituted by at least one group selected from halogen, cyano, nitro, cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR, or -(CO)N(R)2; or NR 18 R 19 Together they form an unsubstituted or substituted heterocyclic group with a nitrogen atom at the 1-position;

[0013] The aforementioned cycloalkyl, heterocyclic, or aryl group is optionally substituted by at least one group selected from oxo, halogen, cyano, nitro, alkyl, alkenyl, ynyl, haloalkyl, haloalkenyl, haloynyl, cycloalkyl, cycloalkylalkyl, heterocyclic, aryl, -OR, -SR, -N(R)2, -N(R)(COOR), -(CO)R, -(CO)OR, -(CO)N(R)2, -(CS)N(R)2, -(SO)R, or -(SO2)R;

[0014] R independently represents hydrogen, alkyl, alkenyl, alkynyl, alkyl, alkenyl or alkynyl substituted with at least one group selected from halogen, hydroxyl, alkoxy, alkylthio, cyano or alkoxycarbonyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, phenyl or phenyl substituted with at least one group selected from halogen, cyano, nitro, alkyl, haloalkyl, alkoxycarbonyl, alkylthio, alkylsulfonyl, alkoxy or haloalkoxy.

[0015] In one specific embodiment, Q represents hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, aryl, heterocyclic, -OR 17 -SR 17 -ON = C(R) 17 )2、-O(CO)NR 18 R 19 -O(CO)OR17 -(CO)R 17 -(CO)OR 17 -(CO)(CO)OR 17 -(CO)NR 18 R 19 , -NR 18 R 19 or The C1-C8 alkyl, C2-C8 alkenyl, and C2-C8 alkynyl groups are optionally selected from halogens, cyano groups, nitro groups, C3-C8 cycloalkyl groups, aryl groups, heterocyclic groups, and -OR groups. 17 -SR 17 -ON = C(R) 17 )2、-O(CO)NR 18 R 19 -O(CO)OR 17 -(CO)R 17 -(CO)OR 17 -(CO)(CO)OR 17 -(CO)NR 18 R 19 , -NR 18 R 19 or At least one group in it is replaced;

[0016] R1, R2, R3, R4, and R5 independently represent hydrogen, halogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, cyano, nitro, C3-C8 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -N(R)(OR), -N(R)(COR), -O(CO)R, -O(CO)OR, -(CO)R, and -( CO)OR or -(CO)N(R)2; wherein the C1-C8 alkyl, C2-C8 alkenyl or C2-C8 alkynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C8 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R or -(CO)N(R)2;

[0017] R6, R9, R 10 R 11 R 12 R 13 R 14 R 15 R 16Each of these can independently represent hydrogen, halogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, halo-C1-C8 alkyl, halo-C2-C8 alkenyl, halo-C2-C8 alkynyl, cyano, cyano-C1-C8 alkyl, -OR, -(C1-C8 alkylene)-OR, -(CO)OR, or C3-C8 cycloalkyl;

[0018] R 17 Represents hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 ynyl, C3-C8 cycloalkyl, aryl, or heterocyclic group; wherein the C1-C8 alkyl, C2-C8 alkenyl, or C2-C8 ynyl group is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C8 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)N(R)2, or -(CO)N(R)(OR);

[0019] R7, R8, R 18 R 19 Each of these groups independently represents hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 ynyl, C3-C8 cycloalkyl, aryl, heterocyclic, -N(R)2, -N(R)(OR), -COR, -COOR, -OR, -SOR, or -(SO2)R; wherein the C1-C8 alkyl, C2-C8 alkenyl, or C2-C8 ynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C8 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR, or -(CO)N(R)2; or NR 18 R 19 Together they form an unsubstituted group or a group substituted by at least one group selected from oxo, halogen, C1-C8 alkyl, or C1-C8 alkoxycarbonyl.

[0020] The aforementioned C3-C8 cycloalkyl, heterocyclic, or aryl group is optionally substituted by at least one group selected from oxo, halogen, cyano, nitro, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 ynyl, halo-C1-C8 alkyl, halo-C2-C8 alkenyl, halo-C2-C8 ynyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl-C1-C8 alkyl, heterocyclic, aryl, -OR, -SR, -N(R)2, -N(R)(COOR), -(CO)R, -(CO)OR, -(CO)N(R)2, -(CS)N(R)2, -(SO)R, or -(SO2)R;

[0021] R independently represents hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkyl, C2-C8 alkenyl or C2-C8 alkynyl substituted with at least one group selected from halogen, hydroxyl, C1-C8 alkoxy, C1-C8 alkylthio, cyano or C1-C8 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl C1-C8 alkyl, C3-C8 cycloalkenyl, C3-C8 cycloalkenyl C1-C8 alkyl, phenyl or phenyl substituted with at least one group selected from halogen, cyano, nitro, C1-C8 alkyl, halo-C1-C8 alkyl, C1-C8 alkoxycarbonyl, C1-C8 alkylthio, C1-C8 alkylsulfonyl, C1-C8 alkoxy or halo-C1-C8 alkoxy.

[0022] In another specific embodiment, Q represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, aryl, heterocyclic, -OR 17 -SR 17 -ON = C(R) 17 )2、-O(CO)NR 18 R 19 -O(CO)OR 17 -(CO)R 17 -(CO)OR 17 -(CO)(CO)OR 17 -(CO)NR 18 R 19 , -NR 18 R 19 or The C1-C6 alkyl, C2-C6 alkenyl, and C2-C6 alkynyl groups are optionally selected from halogens, cyano groups, nitro groups, C3-C6 cycloalkyl groups, aryl groups, heterocyclic groups, and -OR groups. 17 -SR 17 -ON = C(R) 17 )2、-O(CO)NR 18 R 19 -O(CO)OR 17 -(CO)R 17 -(CO)OR 17 -(CO)(CO)OR 17 -(CO)NR 18 R 19 , -NR 18 R 19 or At least one group in it is replaced.

[0023] In another specific embodiment, R1, R2, R3, R4, and R5 independently represent hydrogen, halogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -N(R)(OR), -N(R)(COR), -O(CO)R, -O(CO)OR, -(C -(CO)OR or -(CO)N(R)2; wherein the C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R or -(CO)N(R)2.

[0024] In another specific embodiment, R6, R9, R 10 R 11 R 12 R 13 R 14 R 15 R 16 Each of these can independently represent hydrogen, halogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogenated C1-C6 alkyl, halogenated C2-C6 alkenyl, halogenated C2-C6 alkynyl, cyano, cyanoC1-C6 alkyl, -OR, -(C1-C6 alkylene)-OR, -(CO)OR, or C3-C6 cycloalkyl.

[0025] In another specific implementation, R 17 Represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 ynyl, C3-C6 cycloalkyl, aryl, or heterocyclic group; wherein the C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 ynyl group is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic group, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)N(R)2, or -(CO)N(R)(OR).

[0026] In another specific embodiment, R7, R8, R 18 R 19Each of these groups independently represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 ynyl, C3-C6 cycloalkyl, aryl, heterocyclic, -N(R)2, -N(R)(OR), -COR, -COOR, -OR, -SOR, or -(SO2)R; wherein the C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 ynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR, or -(CO)N(R)2; or NR 18 R 19 Together they form an unsubstituted group or a group substituted by at least one group selected from oxo, halogen, C1-C6 alkyl, or C1-C6 alkoxycarbonyl.

[0027] In another specific embodiment, the aforementioned C3-C6 cycloalkyl, heterocyclic, or aryl group is optionally substituted by at least one group selected from oxo, halogen, cyano, nitro, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 ynyl, halogenated C1-C6 alkyl, halogenated C2-C6 alkenyl, halogenated C2-C6 ynyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, heterocyclic, aryl, -OR, -SR, -N(R)2, -N(R)(COOR), -(CO)R, -(CO)OR, -(CO)N(R)2, -(CS)N(R)2, -(SO)R, or -(SO2)R.

[0028] In another specific embodiment, R independently represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl substituted with at least one group selected from halogen, hydroxyl, C1-C6 alkoxy, C1-C6 alkylthio, cyano or C1-C6 alkoxycarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylC1-C6 alkyl, C3-C6 cycloalkenyl, C3-C6 cycloalkenylC1-C6 alkyl, phenyl or phenyl substituted with at least one group selected from halogen, cyano, nitro, C1-C6 alkyl, halo-C1-C6 alkyl, C1-C6 alkoxycarbonyl, C1-C6 alkylthio, C1-C6 alkylsulfonyl, C1-C6 alkoxy or halo-C1-C6 alkoxy.

[0029] In another specific implementation, R 17Represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 ynyl, C3-C6 cycloalkyl, aryl, heterocyclic, or -N=CR2; wherein the C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 ynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, or -(CO)N(R)2.

[0030] In another specific embodiment, R7, R8, R 18 R 19 Each of these groups independently represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 ynyl, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SOR, or -(SO2)R; the C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 ynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR, or -(CO)N(R)2; or NR 18 R 19 Together they form an unsubstituted group or a group substituted by at least one group selected from oxo, halogen, C1-C6 alkyl, or C1-C6 alkoxycarbonyl.

[0031] In another specific embodiment, R independently represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl substituted with at least one group selected from halogen, hydroxyl, C1-C6 alkoxy, cyano or C1-C6 alkoxycarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylC1-C6 alkyl, C3-C6 cycloalkenyl, C3-C6 cycloalkenylC1-C6 alkyl, phenyl or phenyl substituted with at least one group selected from halogen, cyano, nitro, C1-C6 alkyl, halo-C1-C6 alkyl, C1-C6 alkoxycarbonyl, C1-C6 alkylthio, C1-C6 alkylsulfonyl, C1-C6 alkoxy or halo-C1-C6 alkoxy.

[0032] In another specific implementation, Q stands for -OR 17 or -NR 18 R 19 .

[0033] In the definitions of compounds shown in the above general formulas and in all the following structural formulas, the technical terms used, whether alone or in compound terms, represent the following substituents: alkyl groups having more than two carbon atoms can be straight-chain or branched. For example, in the compound term "-alkylene-OR", alkylene can be -CH2-, -CH2CH2-, -CH(CH3)-, -C(CH3)2-, etc. Alkyl groups are, for example, C1 alkyl-methyl; C2 alkyl-ethyl; C3 alkyl-propyl such as n-propyl or isopropyl; C4 alkyl-butyl such as n-butyl, isobutyl, tert-butyl, or 2-butyl; C5 alkyl-pentyl such as n-pentyl; C6 alkyl-hexyl such as n-hexyl, isohexyl, and 1,3-dimethylbutyl. Similarly, alkenyl groups are, for example, vinyl, allyl, 1-methylprop-2-en-1-yl, 2-methylprop-2-en-1-yl, but-2-en-1-yl, but-3-en-1-yl, 1-methylbut-3-en-1-yl, and 1-methylbut-2-en-1-yl. Alkynyl groups are, for example, ethynyl, propynyl, but-2-yn-1-yl, but-3-yn-1-yl, and 1-methylbut-3-yn-1-yl. Multiple bonds can be in any position in each unsaturated group. Cycloalkyl groups are carbocyclic saturated ring systems having, for example, three to six carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl. Similarly, cycloalkenyl groups are monocyclic alkenyl groups having, for example, three to six carbon ring members, such as cyclopropenyl, cyclobutenyl, cyclopentenyl, and cyclohexenyl, wherein double bonds can be in any position. Halogens are fluorine, chlorine, bromine, or iodine.

[0034] Unless otherwise specified, the term "aryl" in this invention includes, but is not limited to, phenyl, naphthyl, and... The "heterocyclic group" includes, but is not limited to, saturated or unsaturated non-aromatic cyclic groups. And, including but not limited to, heteroaryl groups, i.e., aromatic cyclic groups containing, for example, 3 to 6 ring atoms and optionally fused with benzo[a] rings, wherein 1 to 4 (e.g., 1, 2, 3, or 4) heteroatoms are selected from oxygen, nitrogen, and sulfur, for example

[0035] The terms "optional" or "optionally" mean that the event or situation described below may or may not occur, and the description includes instances where said event or situation occurs and instances where said event or situation does not occur. For example, the term "optionally...substituted" means that the specified atom or group is unsubstituted or substituted by one or more substituents. If a group is substituted by a group, this should be understood to mean that the group is substituted by one or more groups, either the same or different, selected from those groups mentioned. Furthermore, the same or different substitution characters contained in the same or different substituents are chosen independently and may be the same or different. This also applies to ring systems formed from different atoms and units. Meanwhile, the scope of the claims excludes compounds that are chemically unstable under standard conditions, as known to those skilled in the art.

[0036] Furthermore, unless otherwise specified, the phrase "replaced by at least one group" in this invention refers to being replaced by, for example, 1, 2, 3, 4, or 5 groups; groups without specific attachment positions (including heterocyclic groups, aryl groups, etc.) can be attached at any position, including positions attached to C or N; if it is substituted, the substituent can also be substituted at any position, as long as it conforms to the rules of chemical bond attachment. For example, a heteroaryl group substituted by one methyl group. Can represent wait.

[0037] This invention provides a 3-phenylisoxazoline-5-carboxamide compound having a chiral center as shown in Formula I', or a salt thereof:

[0038] In this context, the carbon atom at position * is the chiral center, and the substituents R1, R2, R3, R4, R5, R6, R7, Q, X, and Z are defined as described above.

[0039] In one specific embodiment, based on the content of stereoisomers having R and S configurations at position *, it has a stereochemical purity of 60-100%, preferably 70-100%, more preferably 80-100%, further preferably 90-100%, and even more preferably 95-100%.

[0040] This invention provides a 3-phenylisoxazoline-5-carboxamide compound having a chiral center as shown in Formula I”, or a salt thereof:

[0041] In this context, the carbon atom at position * is the chiral center, and the substituents R1, R2, R3, R4, R5, R6, R7, Q, X, and Z are defined as described above.

[0042] In one specific embodiment, based on the content of stereoisomers having R and S configurations at position *, it has a stereochemical purity of 60-100%, preferably 70-100%, more preferably 80-100%, further preferably 90-100%, and even more preferably 95-100%.

[0043] "Stereochemical purity" refers to the percentage of the amount of the stereoisomer relative to the total amount of stereoisomers that generate chiral centers.

[0044] In this invention, the stereochemical configuration at the position marked * in Formula I is determined to be predominantly (R) or (S) according to the Cahn-Ingold-Prelog system; however, the subject matter of this invention also relates to all stereoisomers at other positions included in Formula I, and mixtures thereof. Such Formula I compounds contain, for example, one or more additional asymmetric carbon atoms or other double bonds not specifically described in Formula I. It should be understood that this invention includes pure isomers and mixtures thereof enriched to varying degrees with pure isomers, wherein the asymmetric carbon atom at the position marked * is in R-configuration or S-configuration, or in the mixture, the compound or a compound with the same chemical structure has R-configuration or S-configuration at the position marked *, or is present in a proportion predominantly having R-configuration or S-configuration (at least 60% R-configuration or S-configuration), while other asymmetric carbon atoms may be present in racemic form or may be resolved to varying degrees. Possible stereoisomers defined by a specific spatial form, such as enantiomers, diastereomers, Z- and E-isomers, are included in Formula I, provided that the stereochemical configuration conditions at the position marked as * are met. They can be obtained from mixtures of stereoisomers by conventional methods or prepared by stereoselective reactions in conjunction with stereochemically pure initial substances.

[0045] If various functional groups are present, the present invention also includes any ketone and enol tautomer forms, mixtures thereof, and salts thereof.

[0046] Stereoisomers can be obtained from mixtures prepared by optical resolution. Similarly, stereoisomers can be selectively prepared using stereoselective reactions and optically active starting materials and / or auxiliaries. For optical resolution, conventional methods (see Textbooks of Stereochemistry) can generally be used, such as physical methods for resolving mixtures into diastereomers, including crystallization, chromatography, especially column chromatography and high-performance liquid chromatography, distillation under reduced pressure as needed, extraction, and other methods, typically employing chromatographic separation on a chiral solid phase, which can separate the residual mixture of enantiomers. Suitable for preparative or industrial scales are methods such as crystallizing diastereomers, which can be obtained from the compound using optically active acids, and, if acidic groups are present, using optically active bases as needed.

[0047] The method for preparing the 3-phenylisooxazoline-5-carboxamide compound or its salt includes the following steps:

[0048] (1) The compound of general formula II and the compound of general formula III are reacted to prepare the compound of general formula I. The reaction equation is as follows:

[0049] Where M represents OH or halogen, and the definitions of R1, R2, R3, R4, R5, R6, R7, Q, X and Z are as described above;

[0050] Or (2) as an intermediate The compound represented by general formula I was prepared by reaction.

[0051] In one specific embodiment, the reaction (1) is carried out in the presence of a base and a solvent.

[0052] In another specific embodiment, a condensing agent is added during reaction (1).

[0053] In another specific embodiment, the solvent is selected from at least one of DMF, DMA, acetonitrile, dichloroethane, DMSO, dioxane, dichloromethane, tetrahydrofuran, or ethyl acetate.

[0054] In another specific embodiment, the base is selected from at least one of inorganic or organic bases, such as NaH, KH, NaOH, KOH, K2CO3, Na2CO3, Cs2CO3, KF, CsF, pyrazole, triethylamine, N,N-diisopropylethylamine, pyridine, DIEA, potassium trimethylsilanol, AcOK, AcONa, MeONa, EtONa, t-BuONa, t-BuOK, etc.

[0055] In another specific embodiment, the condensing agent is selected from at least one of Py-BOP, Py-AOP, EDCI, HOBT, DCC, HBTU, or HATU.

[0056] A herbicide composition comprising a herbicidally effective amount of at least one of the 3-phenylisoxazoline-5-carboxamide compounds or their salts.

[0057] In one embodiment, the composition further includes a formulation adjuvant.

[0058] In another embodiment, the composition further includes other active ingredients.

[0059] A method for controlling weeds, comprising applying a herbicidal effective amount of at least one of the 3-phenylisoxazoline-5-carboxamide compounds or salts thereof, or the herbicide composition thereof, to plants or weedy areas.

[0060] The use of at least one of the 3-phenylisooxazoline-5-carboxamide compounds or their salts, or the herbicide composition thereof, in the control of weeds.

[0061] In one specific embodiment, it is used to control weeds in useful crops; optionally, the useful crops are genetically modified crops or crops treated with genome editing technology.

[0062] For many economically important monocotyledonous and dicotyledonous pests, the compounds of Formula I of this invention exhibit outstanding herbicidal activity. The active substances of this invention are also effective against perennial weeds that grow from rhizomes, rootstocks, or other perennial organs and are difficult to control. In this regard, it is generally not important whether the substance is used before sowing, before germination, or after germination. Representative examples of monocotyledonous and dicotyledonous weed populations that can be controlled by the compounds of this invention are specifically mentioned, without limiting the specific species. Examples of weed species to which the active substances are effective include monocotyledons: annuals of *Oat*, *Lolium*, *Alopecurus*, *Fararis*, *Barnyardgrass*, *Digitaria*, *Setaria*, and *Sedge*, and perennials of *Agropyron*, *Cynodon*, *Imperata*, and *Sorghum*, as well as perennials of *Sedge*.

[0063] Regarding dicotyledonous weed species, its effects can be extended to annual species such as *Galium aparine*, *Viola*, *Veronica*, *Sesamum indicum*, *Stellaria*, *Amaranthus*, *Sinapis*, *Ipomoea*, *Heliotropium*, *Chaenomeles*, and *Abutilon*, and perennial weeds such as *Convolvulus*, *Thistle*, *Rumex*, and *Artemisia*. The active substances of this invention effectively control harmful plants such as barnyard grass, *Sagittaria*, *Alisma*, *Eupatorium*, *Sedum*, and *Sedge* under the undetermined condition of rice sowing. If the compounds of this invention are applied to the soil surface before germination, weed seedlings can be completely prevented before they emerge, or growth can be stopped when the weeds develop cotyledons, eventually leading to their complete death after three to four weeks. The compounds of this invention exhibit particularly excellent activity against the following plants: *Apira*, *Sesamum indicum*, *Polygonum cuspidatum*, *Stellaria*, *Veronica ivy*, *Veronica arabiculata*, *Viola tricolor* and *Amaranthus*, *Galium aparine*, and *Kochia scoparia*.

[0064] While the compounds of this invention exhibit excellent herbicidal activity against both monocot and dicot weeds, they cause little to no damage to important economic crops such as wheat, barley, rye, rice, corn, sugar beets, cotton, and soybeans. They are particularly compatible with cereal crops, such as wheat, barley, and corn, especially wheat. Therefore, the compounds of this invention are highly suitable for the selective control of unwanted plants in agricultural or ornamental crops.

[0065] Due to their herbicidal properties, these active substances can be used to control harmful plants in known or future genetically engineered plant cultivation. Transgenic plants typically possess superior traits, such as resistance to specific pesticides, particularly herbicides, and resistance to plant diseases or pathogenic microorganisms, such as specific insects or fungi, bacteria, or viruses. Other specific traits relate to conditions such as quantity, quality, storage stability, composition, and special components of the product. Thus, it is known that transgenic plant products have increased starch content or improved starch quality or different fatty acid compositions.

[0066] The compounds of Formula I of the present invention, or salts thereof, are preferably used in the cultivation of economically important genetically modified crops and ornamental plants, such as cereals, including wheat, barley, rye, oats, millet, rice, cassava, and corn, or in the cultivation of sugar beets, cotton, soybeans, rapeseed, potatoes, tomatoes, peas, and other vegetable plants. The compounds of Formula I are preferably used as herbicides for the cultivation of useful plants that are resistant or have been genetically engineered to be resistant to the toxic effects of the herbicides.

[0067] Traditional methods for breeding plants with improved traits than known plants include, for example, conventional mating methods and mutant breeding. In other words, new plants with improved traits can be obtained using genetic engineering methods (see, for example, EP-0221044A, EP-0131624A). Several methods have been described, for example:

[0068] - To improve starch synthesis in plants, genetic engineering is used to modify crop plants (e.g., WO 92 / 11376, WO92 / 14827, WO 91 / 19806);

[0069] - Transgenic crop plants resistant to specific herbicides, such as glufosinate-methyl (e.g., EP-0242236A, EP-0242246A), glyphosate-based herbicides (WO 92 / 00377), or sulfonylurea herbicides (EP-0257993A, US-5013659A);

[0070] - For example, genetically modified cotton plants can produce Bt toxins, which can defend against certain pests (EP-0142924A, EP-0193259A).

[0071] - A genetically modified crop plant with improved fatty acid composition (WO91 / 13972).

[0072] Many molecular biotechnologies for preparing transgenic plants with improved traits are known (see, for example, Sambrook et al., 1989, Molecular Amplification, Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; or Winnacker, “Gene and Cloning,” VCH Weinheim, 2nd ed., 1996; or Christou, “Trends in Plant Science,” 1 (1996) 423-431). To perform genetic engineering operations, nucleic acid molecules may be introduced into plasmids, resulting in mutations or sequence alterations through DNA sequence recombination. Using standard methods, such as base substitution, removal of portions of the sequence, or addition of natural or synthetic sequences, can be employed. To link DNA fragments together, it is possible to attach conjugates or linkers to the fragments.

[0073] Plant cells containing reduced-activity gene products can be prepared by methods such as expressing at least one appropriate antisense RNA or sense RNA to achieve co-inhibition, or by expressing at least one appropriately constructed ribozyme that specifically cleaves the transcript of the aforementioned gene product.

[0074] For this purpose, it is possible to use a DNA molecule containing the entire coding sequence of the gene product, including any possible flanking sequences, or a DNA molecule containing only a portion of the coding sequence, which must be long enough to achieve an antisense effect in the cell. Alternatively, a sequence that is highly homologous to but not identical to the coding sequence of the gene product can also be used.

[0075] When nucleic acid molecules are expressed in plants, the synthesized proteins can be localized in any desired plant cell compartment. However, to localize in a specific compartment, it is possible, for example, to link the coding region to a DNA sequence to ensure localization at a specific location. These sequences are known to those skilled in the art (see, for example, Braun et al., EMBO J.11 (1992) 3219-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al., Plant J.1 (1991), 95-106).

[0076] Using known techniques, transgenic plant cells can be recombined into the entire plant. Transgenic plants can be any desired plant variety, i.e., monocots and dicots. In this way, it is possible to obtain transgenic plants with improved traits by overexpressing, inhibiting or suppressing homologous (=natural) genes or gene sequences, or by expressing heterologous (=external) genes or gene sequences.

[0077] When the active substances of this invention are used on genetically modified crops, in addition to the inhibitory effect on harmful plants observed in other crops, they often exhibit specific effects on the corresponding genetically modified crops. For example, they can improve or expand the range of weed control, improve the application rate, preferably combine the herbicide resistance of the genetically modified crop with the performance of the herbicide, and affect the growth and yield of the genetically modified crop. Therefore, this invention also provides the use of the compounds as herbicides to control harmful plants in genetically modified crop plants.

[0078] Furthermore, the compounds of this invention can significantly regulate crop growth. By modulating plant metabolism, these compounds can be used to directionally control plant components and promote harvesting, for example, by causing plant drying and dwarfing. They are also suitable for regulating and inhibiting unwanted plant growth without disrupting crop growth. Inhibiting plant growth plays a crucial role in many monocot and dicot crops because it can reduce or completely prevent lodging.

[0079] The compounds of the present invention can be applied using common formulations, including wettable powders, concentrated emulsions, sprayable solutions, powders, or granules. Thus, the present invention also provides herbicide compositions comprising compounds of formula I. Compounds of formula I can be formulated in various ways depending on typical biological and / or chemical physical parameters. Examples of suitable formulation choices include: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, concentrated emulsions (EC), emulsions such as oil dispersed in water and water dispersed in oil (EW), sprayable solutions, suspension concentrates (SC), dispersible oil suspensions (OD), suspensions diluted with oil or water, solutions miscible with oil, powders (DP), capsule suspensions (CS), seeddressing compositions, granules for broadcasting and soil application, spray granules, coating granules and absorbent granules, water-dispersible granules (WG), water-soluble granules (SG), ULV (ultra-low volume) formulations, microcapsules, and wax products. These individual formulation types are known and described in the following literature, for example, Winnacker-Küchler, “Chemische Techonologie” [Chemical Processes], Vol. 7, C. Hauser Verlag Munich, 4th ed. 1986; Wade van Valkenburg, “Pesticide Formulations”, Marcel Dekker, NY, 1973; K. Martens, “Spray Drying” Handbook, 3rd ed. 1979, G. Goodwin Ltd. London.

[0080] Necessary formulation adjuvants, such as inert substances, surfactants, solvents, and other additives, are also known and described in the following documents, for example, Watkins's "Handbook of Powder Diluents, Insecticides, and Carriers," 2nd ed., Darland, Caldwell, NJ; Hv01phen's "Introduction to Clay Colloid Chemistry," 2nd ed., J. Wiley and Sons, NY; C. Marsden's "Solvent Guide," 2nd ed., Interscience, NY 1963; McCutcheon's "Annual Report on Detergents and Emulsifiers," MC Publishing, Ridgewood, NJ; Sisley and Wood, "Encyclopedia of Surfactants," Chemical Publishing, NY 1964; of [Ethylene oxide adduct surfactants], Wiss. Verlagagesell. Stuttgart 1976; Winnacker-Küchler, “Chemische Technologie” [Chemical Processes], Vol. 7, C. Hauser Verlag Munich, 4th edition 1986.

[0081] Wettable powders are uniformly dispersible in water and, in addition to the active ingredient, include diluents or inert substances, ionic and nonionic surfactants (wetting agents, dispersants), such as polyethoxyalkylphenols, polyethoxy fatty alcohols, polyoxyethyl aliphatic amines, fatty alcohol polyethylene glycol ether sulfates, alkyl sulfonates, alkyl phenyl sulfonates, sodium lignosulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate, or sodium oleoylmethyl taurate. To prepare wettable powders, the active ingredient of the herbicide is finely ground, for example using common equipment such as hammer mills, fan mills, and jet mills, while adjuvants are mixed in simultaneously or sequentially.

[0082] Concentrated emulsions are prepared by dissolving active ingredients in an organic solvent, such as butanol, cyclohexanone, dimethylformamide, xylene, or a mixture of higher-boiling aromatic compounds or hydrocarbons, and then adding one or more ionic and / or nonionic surfactants (emulsifiers). Examples of emulsifiers that can be used include, for example, calcium alkylaryl sulfonate of calcium dodecylbenzenesulfonate, or nonionic emulsifiers such as fatty acid polyethylene glycol esters, alkyl aromatic polyethylene glycol ethers, fatty alcohol polyethylene glycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters such as sorbitan fatty acid esters, or polyethylene oxide sorbitan esters such as polyethylene oxide sorbitan fatty acid esters.

[0083] The active substance and finely ground solid material are ground to obtain a powder. The solid material may be talc, natural clay such as kaolin, bentonite, and pyrophyllite, or diatomaceous earth. A water- or oil-based suspension may be prepared, for example, by wet grinding using a commercially available glass bead mill, with or without the addition of a surfactant of the other formulation type mentioned above.

[0084] Emulsions, such as oil-in-water (EW) emulsions, can be prepared using an aqueous organic solvent, a stirrer, a colloid mill, and / or a static mixer, and if necessary, by adding a surfactant of another formulation type as described above.

[0085] Granules can be prepared by spraying the active material onto an adsorbent and granulating it using an inert material, or by concentrating the active material onto the surface of a carrier such as sand or kaolinite and granulating it using a binder such as polyvinyl alcohol, sodium polyacrylate, or mineral oil. Suitable active materials can be granulated using methods for preparing fertilizer granules, and fertilizers can be mixed in if necessary. Aqueous suspension granules can be prepared using conventional methods such as spray-drying, fluidized bed granulation, disc granulation, mixing using a high-speed mixer, and extrusion without solid inert material.

[0086] For methods of preparing granules using grinding discs, fluidized beds, extruders, and spraying, see the following processes, for example, “Spray Drying Handbook,” 3rd edition, 1979, G. Goodwin Ltd., London; J.E. Browning, “Agglomeration,” Chemicals and Engineering, 1967, 147ff; “Perry’s Chemical Engineer’s Handbook,” 5th edition, McGraw-Hill, New York, 1973, 8–57. For information on formulations of crop protection products, see, for example, G.K. C. Lingman, “Weed Control as a Science,” John Wiley and Sons, New York, 1961, 181–96; and JD. F. Greyer, SAEvans, “Weed Control Handbook,” 5th edition, Blackwell Scientific Rublications, Oxford University Press, 1968, 101–103.

[0087] Agricultural chemical formulations typically contain 0.1% to 99%, particularly 0.1% to 95%, of active ingredient Formula I by weight. The concentration of active ingredient in wettable powders is, for example, from about 10% to 99% by weight, with the usual formulation components constituting the remainder to 100% by weight. The concentration of active ingredient in concentrated emulsions can be from about 1% to 90% by weight, preferably 5% to 80%. Powder formulations contain 1% to 30% active ingredient by weight, typically preferably 5% to 20% by weight; however, sprayable solutions contain about 0.05% to 80% by weight, preferably 2% to 50% by weight. The content of active ingredient in aqueous suspension granules depends primarily on whether the active ingredient is liquid or solid, and on the adjuvants, fillers, etc., used during granulation. The content of active ingredient in aqueous suspension granules is, for example, between 1% and 95% by weight, preferably between 10% and 80% by weight.

[0088] The formulation of the active substance may also include thickeners, wetting agents, dispersants, emulsifiers, penetrants, preservatives, antifreeze agents, solvents, fillers, carriers, colorants, defoamers, evaporation inhibitors, and pH and viscosity adjusters that are commonly used in all cases.

[0089] Based on these formulations, they may also be mixed with other pesticide active substances such as insecticides, acaricides, herbicides and fungicides, as well as with safeners, fertilizers and / or plant growth regulators. The mixing method may be pre-mixed or bottled.

[0090] Suitable active substances that can be mixed with the active substances of the present invention in compound formulations or tank-mixed formulations include, for example, known substances in the "World Encyclopedia of New Pesticide Varieties Technology", China Agricultural Science and Technology Press, 2010.9 and the literature cited herein. For example, the following herbicidal active substances can be mixed with compounds of Formula I (Note: the name of the compound is either the common name according to the International Organization for Standardization (ISO) or the chemical name, with a code where appropriate): acetochlor, butachlor, metolachlor, isopropachlor, isopropachlor, succinyl-metolachlor, propachlor, chlorpyrifos, chlorpyrifos, naphthalenepropanoyl-methyl, R-L-naphthalenepropanoyl-methyl, propargyl, benzylthiamethoxam, bisbenzyl-methyl, pyrifluquinazon, chlorpyrifos, flubutyroxychlor, brobutyroxychlor, dimethoate, high-efficiency dimethoate, ethoxybenzyl-methyl, flubutyroxychlor, methoxythiamethoxam, pyrifluquinazon, isoxachlor, high-efficiency methylparaben, high-efficiency methylparaben. Acetaminophen, clethodim, butyrazosulfuron, cyprochloraz, flusulfuron, heptanosulfuron, isobutyrazosulfuron, propyzamide, terbutyrazosulfuron, methylparaben, metolachlor, methylcyclohexane, chlorpyrifos, propyzamide, pendimethalin, carbaryl, succinylmethrin, tricyclomethrin, butyrazosulfuron, succinylmethrin, bensulfuron-methyl, naphthylmethrin, acetochlor, naphthylmethrin, thiamethoxam, pyrimethanil, bensulfuron-methyl, chlorpyrifos, butyrazosulfuron, flupyrazole, atrazine, simazine, promethazine, cypermethrin, cypermethrin, atrazine, pyrazosulfuron, isopropazine, flumethrin, terbutyraz, terbutyraz, triazine flumethrin, cyprochlorazine, glyphosate, chlorpyrifos Phosphatidylcholine, Simazine, Ziziphus jujuba, Dichlorvos, Isoamyl acetate, Cyprodinil, Atrazine, Butyraz, Butyraz, Terbutaline, Methoxypropazine, Cypermethrin, Herbicides, Clonazine, Atrazine, Methoxypropazine, Glycyrrhizin, Cyanobacterium trioxide, Indaziflam, Greensulfuron, Methsulfuron-methyl, Benzylsulfuron, Chlorpyrifos, Bensulfuron-methyl, Thisulfuron-methyl, Pyrimisulfuron-methyl, Methiosulfuron-methyl, Sodium formamide sulfuron, Ethersulfuron-methyl, Etherbensulfuron-methyl, Methsulfuron-methyl, Nicosulfuron-methyl, Aminosulfuron-methyl, Acylsulfuron-methyl, Ethoxysulfuron-methyl, Cyprosulfuron-methyl, Sulfadiazine, Tetraazolidinylsulfuron, Pyrimisulfuron, Monosulfuron-methyl, Fluazolidinylsulfuron, Flupyrimisulfuron, Flupyrimisulfuron, Epimethrin Sulfuric acid, pyrazosulfuron, flusulfuron, propanil, trifluprosulfuron, sulfonylsulfuron, trifluralin, flusulfanil, trifluralin, mesosulfuron sodium salt, flupyrsulfuron, thiosulfuron, pyrimethanil, propyrisulfuron, pyrazosulfuron, trifluralin, flusulfanilamide, quizalofop-p-ethyl, ethoxysulfuron, glufosinate, bensulfuron, chlorfluazuron ethyl, methylfluzoxystrobin, trifluralin, methoxysulfuron, trifluralin, flufenoxuron, flufenoxuron, oxysulfuron, metolachlor, sulfadiazine, flufenoxuron, oxysulfuron, metolachlor, flufenoxuron, flufenoxuron, halosafen, chlormequat chloride, isoproturon, linuron, diuronSaprolegnia, fluroxypyr, bensulfuron, methyl bensulfuron, bensulfuron, sulfothiamethoxam, isoxaflutole, terbutaline, clodinafop-methyl, chlorobromosulfuron, methyl methoxysulfuron, methyl methoxysulfuron, bromosulfuron, methoxysulfuron, chlorpyrifos, metribuzin, cycloroxysulfuron, felsulfuron, flusulfuron, glufosinate, fensulfuron, cyproconazole, thiamethoxam, fensulfuron, chlorpyrifos, methamidophos, thiamethoxam, trimethourea, oxazolium, Monisouron, Anisuron, Methiuron, Chloreturon, tetraflufenozide, betaine, betaine-ethyl, betaine, sulfonamide, terbutaline, fensulfuron-methyl, fensulfuron-methyl, fensulfuron-methyl, fensulfuron-methyl, chlorpyrifos, carboxazo le, Chlorprocarb, Fenasulam, BCPC, CPPC, Carbasulam, Butyrazosulfan, Clethodim, Metrazine, Clethodim, Wild Grass, Permethrin, Clethodim, Barnyardgrass, Cypermethrin, Oat Grass, Dimethoate, Ethylmethazine, Methiobencarb, Clethodim, Benzoate, Methiobencarb, Thionylmethazine, Methiobencarb, 2,4-D Butyl Acetate, 2,4-D Sodium Chloride, 2,4-D Isooctyl Acetate, 2,4-D Sodium Salt, 2,4-D Dimethylamine Salt, 2,4-D Chlorethyl Thiate, 2,4-D Chloride, 2,4-D Propionic Acid, High 2,4-D Propionate, 2,4-D Butyric Acid, 2,4-D Chlorpropionic Acid, 2,4-D Propionate 2,4,5-chlorobutyric acid, 2,4,5-propylpropionic acid, 2,4,5-propylbutyric acid, 2,4,5-chloromethacin, MCPA, dicamba, quizalofop-p-ethyl, cyhalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, cyhalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl, quizalofop-p-ethyl In, proponitrophenol, glyphosate, barnyardphos, glufosinate, methyl parathion, glyphosate, piperazine, diammonium phosphate, dimethoate, phosmet, fenpropathrin, fenpropathrin, fenpropathrin, dimethoate, fenpropathrin, imidacloprid, imidacloprid acetic acid, imidacloprid quinolinic acid, methoxymethylene, methoxymethylene ammonium salt, imidacloprid acetic acid, imidacloprid, clopyralid, clopyralid isooctyl ester, dichloropyridine acid, aminopyridine acid, trichloropyridine acid, fluthion, haloxypyridine, trichloropyridine phenol, thiamethoxam, flupyridine, clopyralid, flupyridine hydrazone, trichloropyridine butoxyethyl ester, cliodinate, clethodim, thiamethoxam, quizalofop-p-ethyl, cyclobenzanone, butenazine, oxadiazine, pyranazine, buthidazole, cyproconazoleAmetridione, Amibuzin, bromobenzonitrile, octanoyl bromobenzonitrile, octanoyl iodobenzonitrile, iodobenzonitrile, diphenylacetonitrile, bispyribac-sodium, hydroxybispyribac-sodium, Iodobonil, pyrimisulfuron-methyl, diflubenzuron, penoxsulam, sulfadiazine, chlorpyrifos-sulfuron-methyl, dichlorvos-sulfuron-methyl, fluroxypyr, bispyribac-sodium, pyrimisulfuron-methyl, pyrimisulfuron-methyl, pyrimisulfuron-methyl, bispyribac-sodium, nicosulfuron-methyl, sulfadiazine, Tembotrione, Tefuryltrione, Bicyclopyrone, Ketospiradox, isoxazolidinone, isoxazolidinone, Fenoxasulfone, M ethiozolin, isopropalazine, pyrazosulfuron, pyrazosulfuron, pyrazosulfuron, bensulfuron, pyrazosulfuron, pyrazosulfuron, pyrazosulfuron, pyrazosulfuron, flumetsulam, pyrazosulfuron, pyrazosulfuron, flumethrin, pyrazosulfuron, flupropacil, pyrazosulfuron, pyrazosulfuron, pyrazosulfuron, flupropacil ... Herbicides, fluazinam, methyl methacrylate, tetrazolium chlorpyrifos, flupyridamole, chlorpyrifos, bromochlor, dimethomorph, pyrazosulfuron, cyprodinil, pyrazosulfuron, pyrazosulfuron, pyrazosulfuron, pyrazosulfuron, cyprodinil, pyrazosulfuron, bentazon, pyrazosulfuron, oxadiazon, cyprodinil, isoxadiazon, cyprodinil, isopropyl methoxysulfuron, cyprodinil, indicarb, sodium chlorate Herbicides, trichloroacetic acid, monochloroacetic acid, hexachloroacetone, tetrafluoropropionic acid, forage grass, bromophenol oxime, triazole sulfonate, methomyl, furazolidone, furazolidone, ethoxysulfuron, pyrimethanil, chlorpyrifos, flurfluthrin, barnyardgrass, acrolein, bensulfuron-methyl, metribuzin, oat ester, thiamethoxam, styracil, hydroxylone, methoxybenzone, pyrimethanil, chlorpyrifos, trichloropropionic acid, Al orac, Diethamquat, Etnipromid, Iprymidam, Ipfencarbazone, Thiencarbazone-methyl, Pyrimisulfan, Chlorflurazole, Tripropindan, Sulglycapin, methylsulfuron, Cambendichlor, Cyproterinic acid, Thiamethoxam, cypermethrin, cypermethrin, cypermethrin, cypermethrin, cypermethrin, cypermethrin, cypermethrin, pyrazole cypermethrin, furazolidone, oxadiazon, bis(oxazolyl)acrylic acid, dichloropropenylamine, fluorochloropyridinium, DOW fluorochloropyridinium, UBH-509D489, LS82-556, KPP-300, NC-324, NC-330, KH-218, DPX-N8189, SC-0744, DOWCO5 35. DK-8910, V-53482, PP-600, MBH-001, KIH-9201, ET-751, KIH-6127 and KIH-2023. ,

[0091] When used, commercially available formulations are diluted in a common manner if necessary, such as with water for wettable powders, concentrated emulsions, suspensions, and granules suspended in water. Powders, granules for soil application, or solutions for broadcasting and spraying generally do not require further dilution with an inert substance before use. The required dosage of Formula I compound varies with external conditions, such as temperature, humidity, and the nature of the herbicide used. It can vary considerably, for example, from 0.001 to 1.0 kg ai / ha, or more active ingredient, but is preferably between 0.005 and 750 g ai / ha, particularly between 0.005 and 250 g ai / ha. Detailed Implementation

[0092] The following examples are for illustrative purposes only and should not be construed as limiting the invention in any way. The scope of protection of this invention is defined by the claims.

[0093] Given the economic efficiency and diversity of the compounds, we preferentially synthesized a number of compounds, some of which are listed in Table 1 below. Specific compound structures and corresponding compound information are shown in Tables 1-2. The compounds in Table 1 are only for better illustration of the present invention and do not limit the invention. Those skilled in the art should not interpret this as limiting the scope of the above-mentioned subject matter of the invention to the following compounds.

[0094] Table 1. Compound Structures

[0095] Table 2 Compounds 1 H NMR

[0096] Table A has the same structure as Table 1 above, except that the general formula I is replaced with a general formula having a chiral center. In Table A, the entries under the “Serial Number” column heading are described sequentially as 1'-255'. For example, 1' corresponds to the compound 1 in Table 1 in which the chiral carbon at the * position of the general formula has the configuration described.

[0097] Table B has the same structure as Table 1 above, except that the general formula I is replaced with a general formula with a chiral center. In Table A, the entries under the “Serial Number” column heading are described sequentially as 1”-255”. For example, 1” corresponds to the compound 1 in Table 1 in which the chiral carbon at the * position of the general formula has the configuration described.

[0098] Several methods for preparing the compounds of the present invention are described in detail in the following schemes and examples. The raw materials can be commercially available or prepared by methods known in the literature or as detailed in the description. Those skilled in the art will understand that other synthetic routes can also be used to synthesize the compounds of the present invention. Although specific raw materials and conditions in the synthetic routes have been described below, they can be easily replaced with other similar raw materials and conditions. Such variations or modifications to the preparation methods of the present invention, such as various isomers of the compounds, are all included within the scope of the present invention. Furthermore, the preparation methods described below can be further modified according to the disclosure of the present invention using conventional chemical methods well known to those skilled in the art. For example, protecting appropriate groups during the reaction process, etc.

[0099] The following method examples are provided to further illustrate the preparation methods of the present invention. The specific substances, types, and conditions used are intended to further explain the invention and are not intended to limit its reasonable scope. The reagents used in the synthetic compounds shown below are either commercially available or can be easily prepared by those skilled in the art.

[0100] Examples of representative compounds are given below. The synthesis methods of other compounds are similar and will not be described in detail here.

[0101] 1. Synthesis of compound 16'

[0102] (1) In a 50 mL single-necked flask, compound 16-1 (300 mg, 1.18 mmol) was dissolved in 3 mL of dichloromethane. Oxaloyl chloride (226 mg, 1.78 mmol) was added dropwise under ice bath conditions, followed by 1 drop of N,N-dimethylformamide. The reaction was allowed to proceed for 0.5 h, and LCMS was used to monitor the reaction until complete. The reaction solution was concentrated to obtain crude product 16-2. In a 50 mL single-necked flask, compound 16-3 (330 mg, 1.77 mmol) was dissolved in 5 mL of dichloromethane. Triethylamine (900 mg, 8.91 mmol) was added, and a 5 mL solution of 16-2 in dichloromethane was added dropwise under ice bath conditions. The reaction was allowed to proceed for 0.5 h, and LCMS was used to monitor the reaction until complete. The reaction solution was quenched with water, extracted with dichloromethane, dried and concentrated, and the residue was purified by column chromatography to obtain compound 16-4 (400 mg, yield 80.16%, colorless oil).

[0103] (2) In a 50 mL single-necked flask, compound 16-4 (400 mg, 0.95 mmol) was dissolved in 5 mL of dichloromethane, and trifluoroacetic acid (542 mg, 4.75 mmol) was added. The reaction was carried out at room temperature for 0.5 h, and the reaction was monitored by LCMS until it was complete. The reaction solution was concentrated to obtain compound 16-5 (crude product, colorless oil).

[0104] (3) In a 50 mL single-necked flask, compound 16-5 (crude product) was dissolved in 5 mL of dichloromethane, and triethylamine (481 mg, 4.75 mmol) and compound 16-6 (255 mg, 1.90 mmol) were added. The mixture was reacted at room temperature for 0.5 h, and the reaction was monitored by LCMS to ensure complete reaction. The reaction solution was quenched with water, extracted with ethyl acetate, dried and concentrated organic phase, and the residue was purified by column chromatography to obtain compound 16' (200 mg, total yield of two steps 55.55%, pale yellow solid).

[0105] 2. Synthesis of compound 177'

[0106] (1) Substrate 177-1 (1.6 g, 8.1 mmol) was dissolved in 40 mL of DCM. TEA (2.2 g, 22.09 mmol) and 16-2 (2 g, 7.36 mmol) were added sequentially at 0 °C, and the mixture was stirred at room temperature for 0.5 hours under nitrogen protection. LCMS showed that the reaction proceeds were completely reacted, with a major new peak formed. The reaction solution was filtered and concentrated, and the crude product was purified by column chromatography to obtain a light yellow oily substance 177-2 (3.2 g, yield 73.6%).

[0107] (2) To a single-necked flask, 6 mL of dioxane hydrochloride solution was added to 60 mL of 177-2 (3.2 g, 7.3 mmol) DCM solution, and the reaction was carried out at room temperature for 2 h. LCMS showed that the starting material reacted completely, with a major new peak formed. The reaction solution was filtered and concentrated, and the crude product was used directly in the next step.

[0108] (3) Under a nitrogen atmosphere, triphosgene (0.66 g, 2.22 mmol), sulfonamide (0.25 g, 2.22 mmol), and triethylamine (0.45 g, 4.5 mmol) were added sequentially to 10 mL of a toluene solution containing 177-3 (0.5 g, 1.49 mmol), and the reaction was carried out at 90 °C for 8 h. LC-MS showed that the starting material reacted completely, with a major new peak forming. The reaction solution was concentrated, and the crude product was purified by column chromatography to obtain a light yellow oily substance 177' (52 mg, yield 7.7%).

[0109] 3. Synthesis of compound 180'

[0110] (1) Compound 180-1 (1.6 g, 8.1 mmol) was dissolved in 40 mL of dichloromethane. Then, 10 mL solutions of triethylamine (2.2 g, 22.09 mmol) and compound 16-2 (2 g, 7.36 mmol) in dichloromethane were added sequentially at 0 °C. The reaction was carried out at room temperature for 0.5 h under nitrogen protection. LC-MS showed that the starting material reacted completely, with a major new peak forming, accompanied by the mass spectrometric signal of the target product. The reaction solution was concentrated, and the crude product was purified by column chromatography to obtain a light yellow oily substance 180-2 (3.2 g, 73.6%).

[0111] (2) Compound 180-2 (3.2 g, 7.3 mmol) was dissolved in 60 mL of dichloromethane, and 6 mL of dioxane hydrochloride solution was added. The reaction was carried out at room temperature for 2 h. LCMS showed that the starting material reacted completely, with a major new peak forming, accompanied by the mass spectrum signal of the target product. The reaction solution was filtered and concentrated to obtain crude product 180-3, which was used directly in the next step without purification.

[0112] (3) Compound 180-3 (0.2 g, 0.6 mmol) was dissolved in 40 mL of dichloromethane, and triethylamine (0.18 g, 1.8 mmol) and diethyl pyrocarbonate (0.49 g, 3.5 mmol) were added sequentially. The reaction was carried out at room temperature for 0.5 h under nitrogen protection. LCMS showed that the starting material reacted completely, with a major new peak formed, accompanied by the mass spectrum signal of the target product. The reaction solution was concentrated, and the crude product was purified by column chromatography to obtain a light yellow oily substance 180' (70 mg, 28.9%).

[0113] 3. Synthesis of compound 187'

[0114] (1) Compound 187-1 (500 mg, 1.82 mmol, 1.0 eq.) was dissolved in 5 mL of dichloromethane. Compound 187-2 (373 mg, 2.00 mmol, 1.1 eq.), triethylamine (553 mg, 5.46 mmol, 3.0 eq.), and PyBOP (1.14 g, 2.18 mmol, 1.2 eq.) were added sequentially at 0 °C. The reaction was carried out at room temperature for 2 h, and the reaction was monitored by LCMS to ensure complete reaction. The reaction solution was diluted with water and dichloromethane. The organic phase was washed sequentially with saturated ammonium chloride solution and saturated brine solution, dried and concentrated. The residue was purified by column chromatography to obtain compound 187-3 (480 mg, 59.5%).

[0115] (2) Compound 187-3 (480 mg, 1.08 mmol, 1.0 eq.) was dissolved in 5 mL of dichloromethane, and 3 mL of trifluoroacetic acid was added at room temperature. The reaction was allowed to proceed for 4 h. The reaction was monitored by LCMS until complete. The reaction solution was concentrated to obtain crude compound 187-4 (350 mg, 94.3%), which was used directly in the next step.

[0116] (3) Compound 187-4 (350 mg, 1.02 mmol, 1.0 eq.) was dissolved in 5 mL of dichloroethane. Triphosgene (364 mg, 1.23 mmol, 1.2 eq.) and pyridine (242 mg, 3.07 mmol, 3.0 eq.) were added sequentially at room temperature. After reacting for 30 min, dimethyl sulfinyl imide (114 mg, 1.23 mmol, 1.2 eq.) was added, and the reaction was carried out at 85 °C for 24 h. The reaction was monitored by LCMS until complete. The reaction solution was quenched with water, the aqueous phase was extracted with dichloromethane, the organic phase was washed with saturated brine, dried and concentrated, and the residue was purified by reversed-phase column chromatography to obtain compound 187' (70 mg, 14.7%).

[0117] Bioactivity evaluation:

[0118] The activity level standards for plant damage (i.e., growth control rate) are as follows:

[0119] Level 9: Complete death;

[0120] Level 8: Growth control rate is greater than or equal to 90% and less than 100%;

[0121] Level 7: Growth control rate is greater than or equal to 80% and less than 90%;

[0122] Level 6: Growth control rate is greater than or equal to 70% and less than 80%;

[0123] Level 5: Growth control rate is greater than or equal to 50% and less than 70%;

[0124] Level 4: Growth control rate is greater than or equal to 30% and less than 50%;

[0125] Level 3: Growth control rate greater than or equal to 20% and less than 30%;

[0126] Level 2: Growth control rate greater than or equal to 10% and less than 20%;

[0127] Level 1: Growth control rate less than 10%;

[0128] Level 0: No effect.

[0129] The above growth control rates are fresh weight control rates.

[0130] Pre-seeding test:

[0131] Dry direct seeding with closed-cell ammunition: Monocotyledonous and dicotyledonous weed seeds and crop seeds were placed in plastic basins filled with soil, then covered with 0.5-2 cm of soil. The tested compound of this invention was dissolved in acetone, then Tween 80 was added, and the solution was diluted with a certain amount of water to a specific concentration. The solution was sprayed immediately after sowing. The results were observed after two weeks of cultivation in a greenhouse following application.

[0132] Water-directed closed-loop method: Monocotyledonous and dicotyledonous weed seeds and crop seeds were placed in plastic basins filled with soil, covered with 0.5-1cm of soil, and then placed in plastic boxes containing a 3-5cm water layer, ensuring the soil was fully moist but without a visible water layer on the surface. The tested compounds of this invention were dissolved in acetone, then Tween 80 was added, and the solution was diluted with water to a specific concentration. The solutions were sprayed immediately after sowing. After application, the plastic boxes were kept at a water level and incubated in a greenhouse for 2 weeks. The experimental results were then observed. Representative data are listed in Table 3.

[0133] Table 3 Results of the pre-emergence weed test

[0134] Post-emergence testing:

[0135] Seeds of monocot and dicot weeds, as well as seeds of major crops, were placed in plastic pots filled with soil and covered with 0.5-2 cm of soil. The plants were then allowed to grow in a suitable greenhouse environment. Two weeks after sowing, test plants were treated at the 1-6 leaf stage. The tested compound of this invention was dissolved in acetone, and then Tween 80 was added. Methyl oleate emulsifiable concentrate at 1.5 L / ha was used as a synergist, and the solution was diluted with water to a specific concentration. The solution was then sprayed onto the plants using a spray tower. The experimental effects on weeds were statistically analyzed after two weeks of cultivation in the greenhouse following application. Representative data are listed in Table 4.

[0136] Table 4 Results of post-emergence weed test (120g ai / ha)

[0137] Furthermore, numerous tests have revealed that the compounds and compositions described in this invention can control many key grass weeds, sedge weeds, and broadleaf weeds. Tests on wheat, peanuts, soybeans, rice, cotton, sorghum, and other crops under different application methods have also demonstrated excellent selectivity and commercial value.

Claims

1. A 3-phenylisoxazoline-5-carboxamide compound of the formula I: ###0001### or a salt thereof. wherein X represents NR8, O or S; Z represents wherein a, b, c, d are linked to the group X; Q represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, -OR 17 , -SR 17 , -0-N=C(R 17 )2, -0(CO)NR 18 R 19 , -0(CO)OR 17 , -(CO)R 17 , -(CO)OR 17 , -(CO)(CO)OR 17 , -(CO)NR 18 R 19 , -NR 18 R 19 or said alkyl, alkenyl, alkynyl are optionally substituted with one or more substituents selected from the group consisting of halogen, cyano, nitro, cycloalkyl, aryl, heterocyclyl, -OR 17 , -SR 17 , -O-N=C(R 17 )2, -O(CO)NR 18 R 19 , -O(CO)OR 17 , -(CO)R 17 , -(CO)OR 17 , -(CO)(CO)OR 17 , -(CO)NR 18 R 19 , -NR 18 R 19 or substituted by at least one group selected from the group consisting of oxo, halo, cyano, nitro, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, aryl, -OR, -SR, -N(R)2, -N(R)(COOR), -(CO)R, -(CO)OR, -(CO)N(R)2, -(CS)N(R)2, -(SO)R or -(SO2)R; R1, R2, R3, R4, R5independently represent hydrogen, halo, alkyl, alkenyl, alkynyl, cyano, nitro, cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -N(R)(OR), -N(R)(COR), -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR or -(CO)N(R)2; said alkyl, alkenyl or alkynyl is optionally substituted by at least one group selected from halo, cyano, nitro, cycloalkyl, aryl, heterocyclyi, -OR, -SR, -SOR, -(SO2)R, -N(R), -O(CO)R, -O(CO)OR, -(CO)R or -(CO)N(R)2; R6, R9, R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 each independently represents hydrogen, halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, cyano, cyanoalkyl, -OR, -alkylene-OR, -(CO)OR, or cycloalkyl; R 17 represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclyl; said alkyl, alkenyl or alkynyl is optionally substituted with at least one group selected from halogen, cyano, nitro, cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -0(CO)R, -0(CO)OR, -(CO)R, -(CO)N(R)2or -(CO)N(R)(OR); R7, R8, R 18 , R 19 each independently represent hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, -N(R)2, -N(R)(OR), -COR, -COOR, -OR, -SOR or -(SO2)R; said alkyl, alkenyl or alkynyl is optionally substituted with at least one group selected from halogen, cyano, nitro, cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -0(CO)R, -0(CO)OR, -(CO)R, -(CO)OR or -(CO)N(R)2; or NR 18 R 19 together form an unsubstituted or substituted heterocyclyl group having 1 -nitrogen atom in the 1 -position. said cycloalkyl, heterocyclyl or aryl is optionally substituted by at least one group selected from oxo, halo, cyano, nitro, alkyl, alkenyl, alkyny!, haloalkyl, haloalkenyl, haloalkynyl, cycloalkyl, cydoalkylalkyl, heterocyclyl, aryl, -OR, -SR, Rindependently represent hydrogen, alkyl, alkenyl, alkynyl, alkyl, alkenyl or alkynyl substituted by at least one group selected from halo, hydroxy, alkoxy, alkylthio, cyano or alkoxycarbonyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, phenyl or phenyl substituted by at least one group selected from halo, cyano, nitro, alkyl, haloalkyl, alkoxycarbonyl, alkylthio, alkylsulfonyl, alkoxy or haloalkoxy.

2. A 3-phenylisoxazoline-5-carboxamide compound or salt thereof according to claim 1, wherein: R1, R2, R3, R4, R5independently represent hydrogen, alkyl, alkenyl, alkynyl, cyano, nitro, cycioalkyl, aryl, heterocyclyl, -OR, -SR, -N(R)2, -N(R)(OR), -N(R)(COR), said alkyl, alkenyl or alkynyl is optionally substituted by at least one group Q represents hydrogen, Ci-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, aryl, heterocyclyl, -OR 17 , -SR 17 , -0-N=CR 17 2, -0(CO)NR 18 R 19 , -0(CO)OR 17 , -(CO)R 17 , -(CO)OR 17 , -(CO)(CO)OR 17 , -(CO)NR 18 R 19 , -NR 18 R 19 or said C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl groups are optionally substituted with a substituent selected from the group consisting of halogen, cyano, nitro, C3-C8cycloalkyl, aryl, heterocyclyl, -OR 17 , -SR 17 , -O-N=C(R 17 )2, -O(CO)NR 18 R 19 , -O(CO)OR 17 , -(CO)R 17 , -(CO)OR 17 , -(CO)(CO)OR 17 , -(CO)NR 18 R 19 , -NR 18 R 19 or R1, R2, R3, R4, R5independently represent hydrogen; halo; C1-C8 alkyl; C2-C8 alkenyl; C2-C8 alkynyl; cyano; nitro; C3-C8 cycloalkyl; aryl; heterocyclyl; -OR; -SR; -SOR; -(SO2)R; -N(R)2; -N(R)(OR); -N(R)(COR); -O(CO)R; -O(CO)OR; -(CO)R; -(CO)OR; or -(CO)N(R)2; said C1-C8 alkyl, C2-C8 alkenyl or C2-C8 alkynyl is optionally substituted by at least one group selected from halo, cyano, nitlo, C3-C8 cycloalkyl, aryl, heterocyclyl, -OR, -SR; -SOR; -(SO2)R; -N(R)2; -O(CO)R; -O(CO)OR; -(CO)R; or -(CO)N(R)2; ​ R6, R9, R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 each independently represents hydrogen, halogen, Ci-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, halo-Ci-C8alkyl, halo-C2-C8alkenyl, halo-C2-C8alkynyl, cyano, cyano-Ci-C8alkyl, -OR, -(Ci-C8alkylene)-OR, -(CO)OR, or C3-C8cycloalkyl; R 17 represents hydrogen, C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, aryl or heterocyclyl; said C1-C8alkyl, C2-C8alkenyl or C2-C8alkynyl is optionally substituted by at least one radical selected from halogen, cyano, nitro, C3-C8cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)N(R)2or -(CO)N(R)(OR); R7, R8, R 18 , R 19 each independently represent hydrogen, C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, aryl, heterocyclyl, -N(R)2, -N(R)(OR), -COR, -COOR, -OR, -SOR or -(SO2)R; said C1-C8alkyl, C2-C8alkenyl or C2-C8alkynyl being optionally substituted by at least one group selected from halo, cyano, nitro, C3-C8cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR or -(CO)N(R)2; or NR 18 R 19 together form a group which is unsubstituted or substituted by at least one group selected from oxo, halo, C1-C8alkyl or C1-C8alkoxycarbonyl The aforementioned C3-C8 cycloalkyl, heterocyclic, or aryl group is optionally substituted by at least one group selected from oxo, halogen, cyano, nitro, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 ynyl, halo-C1-C8 alkyl, halo-C2-C8 alkenyl, halo-C2-C8 ynyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl-C1-C8 alkyl, heterocyclic, aryl, -OR, -SR, -N(R)2, -N(R)(COOR), -(CO)R, -(CO)OR, -(CO)N(R)2, -(CS)N(R)2, -(SO)R, or -(SO2)R; R independently represents hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkyl, C2-C8 alkenyl or C2-C8 alkynyl substituted with at least one group selected from halogen, hydroxyl, C1-C8 alkoxy, C1-C8 alkylthio, cyano or C1-C8 alkoxycarbonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl C1-C8 alkyl, C3-C8 cycloalkenyl, C3-C8 cycloalkenyl C1-C8 alkyl, phenyl or phenyl substituted with at least one group selected from halogen, cyano, nitro, C1-C8 alkyl, halo-C1-C8 alkyl, C1-C8 alkoxycarbonyl, C1-C8 alkylthio, C1-C8 alkylsulfonyl, C1-C8 alkoxy or halo-C1-C8 alkoxy.

3. A 3-phenylisoxazoline-5-carboxamide compound or a salt thereof according to claim 1 or 2, characterized in that: Q represents hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, aryl, heterocyclyl, -OR 17 , -SR 17 , -0-N=CR 17 2, -0(CO)NR 18 R 19 , -0(CO)OR 17 , -(CO)R 17 , -(CO)OR 17 , -(CO)(CO)OR 17 , -(CO)NR 18 R 19 , -NR 18 R 19 or said C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl groups are optionally substituted with a substituent selected from the group consisting of halogen, cyano, nitro, C3-C6cycloalkyl, aryl, heterocyclyl, -OR 17 , -SR 17 , -O-N=C(R 17 )2, -O(CO)NR 18 R 19 , -O(CO)OR 17 , -(CO)R 17 , -(CO)OR 17 , -(CO)(CO)OR 17 , -(CO)NR 18 R 19 , -NR 18 R 19 or At least one group in it is replaced; R1, R2, R3, R4, and R5 independently represent hydrogen, halogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -N(R)(OR), -N(R)(COR), -O(CO)R, -O(CO)OR, -(CO)R, -( CO)OR or -(CO)N(R)2; wherein the C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl is optionally substituted by at least one group selected from halogen, cyano, nitro, C3-C6 cycloalkyl, aryl, heterocyclic, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R or -(CO)N(R)2; R6, R9, R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 each independently represents hydrogen, halogen, Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, haloCi-C6alkyl, haloC2-C6alkenyl, haloC2-C6alkynyl, cyano, cyanoCi-C6alkyl, -OR, -(Ci-C6alkylene)-OR, -(CO)OR, or C3-C6cycloalkyl; R 17 represents hydrogen, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, aryl or heterocyclyl; said C1-C6alkyl, C2-C6alkenyl or C2-C6alkynyl is optionally substituted with at least one radical selected from halogen, cyano, nitro, C3-C6cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)N(R)2or -(CO)N(R)(OR); R7, R8, R 18 , R 19 each independently represent hydrogen, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, aryl, heterocyclyl, -N(R)2, -N(R)(OR), -COR, -COOR, -OR, -SOR or -(SO2)R; said C1-C6alkyl, C2-C6alkenyl or C2-C6alkynyl being optionally substituted by at least one group selected from halo, cyano, nitro, C3-C6cycloalkyl, aryl, heterocyclyl, -OR, -SR, -SOR, -(SO2)R, -N(R)2, -O(CO)R, -O(CO)OR, -(CO)R, -(CO)OR or -(CO)N(R)2; or NR 18 R 19 together form a group selected from C3-C6cycloalkyl, aryl or heterocyclyl, which is unsubstituted or substituted by at least one group selected from oxo, halo, C1-C6alkyl or C1-C6alkoxycarbonyl; the aforementioned C3-C6cycloalkyl, heterocyclyl or aryl is optionally substituted with at least one radical selected from the group consisting of oxo, halogen, cyano, nitro, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, halogen-C1-C6alkyl, halogen-C2-C6alkenyl, halogen-C2-C6alkynyl, C3-C6cycloalkyl, C3-C6cycloalkyl-C1-C6alkyl, heterocyclyl, aryl, -OR, -SR, -N(R)2, -N(R)(COOR), -(CO)R, -(CO)OR, -(CO)N(R)2, -(CS)N(R)2, -(SO)R or -(SO2)R; R independently represents hydrogen, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkyl, C2-C6alkenyl or C2-C6alkynyl substituted with at least one radical selected from the group consisting of halogen, hydroxy, C1-C6alkoxy, C1-C6alkylthio, cyano or C1-C6alkoxycarbonyl, C3-C6cycloalkyl, C3-C6cycloalkyl-C1-C6alkyl, C3-C6cycloalkenyl, C3-C6cycloalkenyl-C1-C6alkyl, phenyl or phenyl substituted with at least one radical selected from the group consisting of halogen, cyano, nitro, C1-C6alkyl, halogen-C1-C6alkyl, C1-C6alkoxycarbonyl, C1-C6alkylthio, C1-C6alkylsulfonyl, C1-C6alkoxy or halogen-C1-C6alkoxy; Preferably, the compound is selected from any one of Table 1 and Table A.

4. A 3-phenylisoxazoline-5-carboxamide compound having a chiral center as shown in Formula I', or a salt thereof: wherein, the carbon atom in position * is a chiral center, the definitions of the substituents R1, R2, R3, R4, R5, R6, R7, Q, X and Z are as described in any one of claims 1 to 3; Preferably, it has a stereochemical purity of 60-100%, preferably 70-100%, more preferably 80-100%, further preferably 90-100%, and even further preferably 95-100%, based on the content of stereoisomers having the R and S configuration in position *.

5. A 3-phenylisoxazoline-5-carboxamide compound having a chiral center as represented by Formula I" or a salt thereof: ###0002### I" wherein, the carbon atom in position * is a chiral center, the definitions of the substituents R1, R2, R3, R4, R5, R6, R7, Q, X and Z are as described in any one of claims 1 to 3; Preferably, it has a stereochemical purity of 60-100%, preferably 70-100%, more preferably 80-100%, further preferably 90-100%, and even further preferably 95-100%, based on the content of stereoisomers having the R and S configuration in position *.

6. A process for producing a 3-phenylisoxazoline-5-carboxamide compound or a salt thereof according to any one of claims 1 to 5, characterized by, comprising the steps of: (1) reacting a compound of Formula II with a compound of Formula III to produce a compound of Formula I, as shown in the following reaction scheme: wherein M represents OH or halogen, and the definitions of the substituents R1, R2, R3, R4, R5, R6, R7, Q, X and Z are described in any one of claims 1 to 3; or (2) to be an intermediate to obtain a compound of general formula I by reaction; to obtain a compound of general formula I by reaction; Preferably, the reaction (1) is carried out in the presence of a base and a solvent; more preferably, a condensing agent is added during the reaction (1); further preferably, the base is selected from at least one of an inorganic base or an organic base, the solvent is selected from at least one of DMF, DMA, acetonitrile, dichloroethane, DMSO, Dioxane, dichloromethane, tetrahydrofuran or ethyl acetate, and / or the condensing agent is selected from at least one of Py-BOP, Py-AOP, EDCI, HOBT, DCC, HBTU or HATU.

7. A herbicidal composition, characterized by comprising: comprising at least one of the 3-phenylisoxazoline-5-carboxamides or salts thereof according to any one of claims 1 to 5 in a herbicidally effective amount; preferably, further comprising formulation adjuvants; more preferably, further comprising other active ingredients.

8. A method of controlling weeds, characterized by, comprising using at least one of the 3-phenylisoxazoline-5-carboxamides or salts thereof according to any one of claims 1 to 5 or the herbicide composition according to claim 7 in a herbicidally effective amount on a plant or in a weed area.

9. Use of at least one of the 3-phenylisoxazoline-5-carboxamides or salts thereof according to any one of claims 1 to 5 or the herbicide composition according to claim 7 for controlling weeds; preferably, the 3-phenylisoxazoline-5-carboxamides or salts thereof are used for controlling weeds in useful crops; more preferably, the useful crops are genetically modified crops or crops treated with genome editing technology.

10. An intermediate of formula IV according to claim 6.